Clinicopathological characteristics in women with breast cancer in extreme ages in Greece: A single centre experience

[1] Sung, H. et al., ‘Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries’, CA Cancer J Clin, 2021, https://doi.org/10.3322/caac.21660. SungH. ‘Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries’ CA Cancer J Clin 2021 https://doi.org/10.3322/caac.21660. 10.3322/caac.2166033538338 Search in Google Scholar

[2] Howlader, N. et al., SEER Cancer Statistics Review, 1975–2016, 2019. HowladerN. SEER Cancer Statistics Review, 1975–2016 2019 Search in Google Scholar

[3] Schaffar, R. et al., ‘A Population-Based Cohort of Young Women Diagnosed with Breast Cancer in Geneva, Switzerland’, PLoS One 14, 2019, https://doi.org/10.1371/journal.pone.0222136. SchaffarR. ‘A Population-Based Cohort of Young Women Diagnosed with Breast Cancer in Geneva, Switzerland’ PLoS One 14 2019 https://doi.org/10.1371/journal.pone.0222136 10.1371/journal.pone.0222136673092831491032 Search in Google Scholar

[4] Anastasiadi, Z. et al., ‘Breast Cancer in Young Women: An Overview. Updates Surg, 2017’, pp. 313–317. AnastasiadiZ. ‘Breast Cancer in Young Women: An Overview. Updates Surg, 2017’ 313 317 10.1007/s13304-017-0424-128260181 Search in Google Scholar

[5] Johnson, R.H. et al., Breast cancer in adolescents and young adults. Pediatr Blood Cancer, 2018, 65:e27397, https://doi.org/10.1002/pbc.27397, JohnsonR.H. Breast cancer in adolescents and young adults Pediatr Blood Cancer 2018 65 e27397 https://doi.org/10.1002/pbc.27397, 10.1002/pbc.27397619283230156052 Search in Google Scholar

[6] Rosenberg, S.M. et al., ‘BRCA1 and BRCA2 Mutation Testing in Young Women with Breast Cancer’, JAMA Oncol, no. 2, 2016, pp. 730–736, https://doi.org/10.1001/jamaoncol.2015.5941. RosenbergS.M. ‘BRCA1 and BRCA2 Mutation Testing in Young Women with Breast Cancer’ JAMA Oncol 2 2016 730 736 https://doi.org/10.1001/jamaoncol.2015.5941. 10.1001/jamaoncol.2015.5941500289226867710 Search in Google Scholar

[7] Walsh, S.M. et al., ‘Breast Cancer in Young Black Women’, Br J Surg, no. 107, 2020, pp. 677–686, https://doi.org/10.1002/bjs.11401. WalshS.M. ‘Breast Cancer in Young Black Women’ Br J Surg 107 2020 677 686 https://doi.org/10.1002/bjs.11401. 10.1002/bjs.11401742200031981221 Search in Google Scholar

[8] Plichta, J.K. et al., ‘Breast Cancer Tumor Histopathology, Stage at Presentation, and Treatment in the Extremes of Age’, Breast Cancer Res Treat, no. 180, 2020, pp. 227–235, https://doi.org/10.1007/s10549-020-05542-4. PlichtaJ.K. ‘Breast Cancer Tumor Histopathology, Stage at Presentation, and Treatment in the Extremes of Age’ Breast Cancer Res Treat 180 2020 227 235 https://doi.org/10.1007/s10549-020-05542-4. 10.1007/s10549-020-05542-4706643431980967 Search in Google Scholar

[9] Gewefel, H., Salhia, B., ‘Breast Cancer in Adolescent and Young Adult Women’, Clin Breast Cancer, no. 14, 2014, pp. 390–395. GewefelH. SalhiaB. ‘Breast Cancer in Adolescent and Young Adult Women’ Clin Breast Cancer 14 2014 390 395 10.1016/j.clbc.2014.06.00225034440 Search in Google Scholar

[10] Shoemaker, M.L. et al., ‘Differences in Breast Cancer Incidence among Young Women Aged 20–49 Years by Stage and Tumor Characteristics, Age, Race, and Ethnicity, 2004–2013’, Breast Cancer Res Treat, no. 169, 2018, pp. 595–606, https://doi.org/10.1007/s10549-018-4699-9. ShoemakerM.L. ‘Differences in Breast Cancer Incidence among Young Women Aged 20–49 Years by Stage and Tumor Characteristics, Age, Race, and Ethnicity, 2004–2013’ Breast Cancer Res Treat 169 2018 595 606 https://doi.org/10.1007/s10549-018-4699-9 10.1007/s10549-018-4699-9595579229445940 Search in Google Scholar

[11] Desreux, J.A.C., ‘Breast Cancer Screening in Young Women’, Eur J Obstet Gynecol Reprod Biol, no. 230, 2018, pp. 208–211. https://doi.org/10.1016/j.ejogrb.2018.05.018. DesreuxJ.A.C. ‘Breast Cancer Screening in Young Women’ Eur J Obstet Gynecol Reprod Biol 230 2018 208 211 https://doi.org/10.1016/j.ejogrb.2018.05.018. 10.1016/j.ejogrb.2018.05.01829804884 Search in Google Scholar

[12] Ganz, P.A., Bower, J.E., Stanton, A.L., ‘Special Issues in Younger Women with Breast Cancer’, Adv Exp Med Biol, no. 862, 2015, pp. 9–21. https://doi.org/10.1007/978-3-319-16366-6_2. GanzP.A. BowerJ.E. StantonA.L. ‘Special Issues in Younger Women with Breast Cancer’ Adv Exp Med Biol 862 2015 9 21 https://doi.org/10.1007/978-3-319-16366-6_2. 10.1007/978-3-319-16366-6_226059926 Search in Google Scholar

[13] Rossi, L., Mazzara, C., Pagani, O., ‘Diagnosis and Treatment of Breast Cancer in Young Women’, Curr Treat Options Oncol, no. 20, 2018, p. 86. RossiL. MazzaraC. PaganiO. ‘Diagnosis and Treatment of Breast Cancer in Young Women’ Curr Treat Options Oncol 20 2018 86 10.1007/s11864-019-0685-731776799 Search in Google Scholar

[14] Varghese, F., Wong, J., ‘Breast Cancer in the Elderly’, Surg Clin North Am, no. 98, 2018, pp. 819–833. VargheseF. WongJ. ‘Breast Cancer in the Elderly’ Surg Clin North Am 98 2018 819 833 10.1016/j.suc.2018.04.00230005776 Search in Google Scholar

[15] Giugliano, F.M. et al., ‘External Radiotherapy for Breast Cancer in the Elderly’, Aging Clin Exp Res, no. 29, 2017, pp. 149–157. GiuglianoF.M. ‘External Radiotherapy for Breast Cancer in the Elderly’ Aging Clin Exp Res 29 2017 149 157 10.1007/s40520-016-0655-x27837457 Search in Google Scholar

[16] Meresse, M. et al., ‘Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?’, Breast J, no. 23, 2017, pp. 256–266, https://doi.org/10.1111/tbj.12726. MeresseM. ‘Chemotherapy in Old Women with Breast Cancer: Is Age Still a Predictor for Under Treatment?’ Breast J 23 2017 256 266 https://doi.org/10.1111/tbj.12726. 10.1111/tbj.1272628039893 Search in Google Scholar

[17] Ward, S.E. et al., ‘Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data’, Clin Oncol, no. 31, 2019, pp. 444–452, https://doi.org/10.1016/j.clon.2019.03.005. WardS.E. ‘Adjuvant Chemotherapy for Breast Cancer in Older Women: An Analysis of Retrospective English Cancer Registration Data’ Clin Oncol 31 2019 444 452 https://doi.org/10.1016/j.clon.2019.03.005. 10.1016/j.clon.2019.03.00531122807 Search in Google Scholar

[18] Lee, C.S. et al., ‘Screening for Breast Cancer in Women Age 75 Years and Older’, Am J Roentgenol, no. 210, 2018, pp. 256–263, https://doi.org/10.2214/AJR.17.18705. LeeC.S. ‘Screening for Breast Cancer in Women Age 75 Years and Older’ Am J Roentgenol 210 2018 256 263 https://doi.org/10.2214/AJR.17.18705. 10.2214/AJR.17.1870529112471 Search in Google Scholar

[19] Lodi, M et al., ‘Breast Cancer in Elderly Women and Altered Clinico-Pathological Characteristics: A Systematic Review’, Breast Cancer Res Treat, no. 166, 2017, pp. 657–668. LodiM ‘Breast Cancer in Elderly Women and Altered Clinico-Pathological Characteristics: A Systematic Review’ Breast Cancer Res Treat 166 2017 657 668 10.1007/s10549-017-4448-528803352 Search in Google Scholar

[20] Bagegni, N.A., Peterson, L.L., ‘Age-Related Disparities in Older Women with Breast Cancer’, in Advances in Cancer Research, Academic Press Inc., 2020, pp. 23–56. BagegniN.A. PetersonL.L. ‘Age-Related Disparities in Older Women with Breast Cancer’ in Advances in Cancer Research Academic Press Inc. 2020 23 56 10.1016/bs.acr.2020.01.00332241391 Search in Google Scholar

[21] Grumpelt, A.M. et al., ‘Tumor Characteristics and Therapy of Elderly Patients with Breast Cancer’, J Cancer Res Clin Oncol, no. 142, 2016, pp. 1,109–1,116, https://doi.org/10.1007/s00432-015-2111-2. GrumpeltA.M. ‘Tumor Characteristics and Therapy of Elderly Patients with Breast Cancer’ J Cancer Res Clin Oncol 142 2016 1,109 1,116 https://doi.org/10.1007/s00432-015-2111-2. 10.1007/s00432-015-2111-226809246 Search in Google Scholar

[22] Herbst, A., Ingemarsson, I., ‘Intermittent Versus Continuous Electronic Monitoring in Labour: A Randomised Study’, BJOG An Int J Obstet Gynaecol, 1994, https://doi.org/10.1111/j.1471-0528.1994.tb13181.x. HerbstA. IngemarssonI. ‘Intermittent Versus Continuous Electronic Monitoring in Labour: A Randomised Study’ BJOG An Int J Obstet Gynaecol 1994 https://doi.org/10.1111/j.1471-0528.1994.tb13181.x. 10.1111/j.1471-0528.1994.tb13181.x7947499 Search in Google Scholar

[23] Schonberg, M.A. et al., ‘Developing a Patient Decision Aid for Women Aged 70 and Older with Early Stage, Estrogen Receptor Positive, HER2 Negative, Breast Cancer’, J Geriatr Oncol, no. 10, 2019, pp. 980–986, https://doi.org/10.1016/j.jgo.2019.05.004. SchonbergM.A. ‘Developing a Patient Decision Aid for Women Aged 70 and Older with Early Stage, Estrogen Receptor Positive, HER2 Negative, Breast Cancer’ J Geriatr Oncol 10 2019 980 986 https://doi.org/10.1016/j.jgo.2019.05.004. 10.1016/j.jgo.2019.05.00431130442 Search in Google Scholar

[24] Jolly, T.A. et al., ‘Adjuvant Treatment for Older Women with Invasive Breast Cancer’, Women's Heal, no. 12, 2016, pp. 129–146, https://doi.org/10.2217/whe.15.92. JollyT.A. ‘Adjuvant Treatment for Older Women with Invasive Breast Cancer’ Women's Heal 12 2016 129 146 https://doi.org/10.2217/whe.15.92. 10.2217/whe.15.92577957426767315 Search in Google Scholar

[25] Jeon, Y.W. et al., ‘Optimal Treatment of Breast Cancer in Women Older Than 75 Years: A Korea Breast Cancer Registry Analysis’, Breast Cancer Res Treat, no. 178, 2019, pp. 693–701, https://doi.org/10.1007/s10549-019-05426-2. JeonY.W. ‘Optimal Treatment of Breast Cancer in Women Older Than 75 Years: A Korea Breast Cancer Registry Analysis’ Breast Cancer Res Treat 178 2019 693 701 https://doi.org/10.1007/s10549-019-05426-2. 10.1007/s10549-019-05426-2681774131493032 Search in Google Scholar

[26] Gal, O. et al., ‘Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome’, Oncology, no. 94, 2018, pp. 31–38, https://doi.org/10.1159/000480087. GalO. ‘Early Breast Cancer in the Elderly: Characteristics, Therapy, and Long-Term Outcome’ Oncology 94 2018 31 38 https://doi.org/10.1159/000480087. 10.1159/00048008728950265 Search in Google Scholar

[27] Biganzoli, L. et al., ‘Management of Elderly Patients with Breast Cancer: Updated Recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)’, Lancet Oncol, 2012, p. 13, e148–e160. BiganzoliL. ‘Management of Elderly Patients with Breast Cancer: Updated Recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)’ Lancet Oncol 2012 13 e148 e160 10.1016/S1470-2045(11)70383-722469125 Search in Google Scholar

[28] Abdel-Razeq, H. et al., ‘Tumor Characteristics and Treatment Outcomes of Older Patients with Breast Cancer in Jordan’, BMC Womens Health, no. 20, 2020, p. 118, https://doi.org/10.1186/s12905-020-00981-z. Abdel-RazeqH. ‘Tumor Characteristics and Treatment Outcomes of Older Patients with Breast Cancer in Jordan’ BMC Womens Health 20 2020 118 https://doi.org/10.1186/s12905-020-00981-z. 10.1186/s12905-020-00981-z727534232503562 Search in Google Scholar

[29] Erić, I. et al., ‘Breast Cancer in Young Women: Pathologic and Immunohistochemical Features’, Acta Clin Croat, no. 57, 2018, pp. 497–502, https://doi.org/10.20471/acc.2018.57.03.13. ErićI. ‘Breast Cancer in Young Women: Pathologic and Immunohistochemical Features’ Acta Clin Croat 57 2018 497 502 https://doi.org/10.20471/acc.2018.57.03.13. 10.20471/acc.2018.57.03.13653628131168183 Search in Google Scholar

[30] Baban, C.K., Devane, L., Geraghty, J., ‘Change of Paradigm in Treating Elderly with Breast Cancer: Are We Undertreating Elderly Patients?’, Ir J Med Sci, no. 188, 2019, pp. 379–388. BabanC.K. DevaneL. GeraghtyJ. ‘Change of Paradigm in Treating Elderly with Breast Cancer: Are We Undertreating Elderly Patients?’ Ir J Med Sci 188 2019 379 388 10.1007/s11845-018-1851-929934872 Search in Google Scholar

[31] Agborbesong, O. et al., ‘Breast Cancer Treatment in the Elderly: Do Treatment Plans That Do Not Conform to NCCN Recommendations Lead to Worse Outcomes?’, American Journal of Surgery, 2020, pp. 381–384. AgborbesongO. ‘Breast Cancer Treatment in the Elderly: Do Treatment Plans That Do Not Conform to NCCN Recommendations Lead to Worse Outcomes?’ American Journal of Surgery 2020 381 384 10.1016/j.amjsurg.2019.12.00731866003 Search in Google Scholar